1. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Issue 6 (June 2016) Authors: Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Starosławska, Elżbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia Valeria; Magazzù... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current challenges in HER2-positive breast cancer. (February 2016) Authors: Puglisi, Fabio; Fontanella, Caterina; Amoroso, Vito; Bianchi, Giulia Valeria; Bisagni, Giancarlo; Falci, Cristina; Fontana, Andrea; Generali, Daniele; Gianni, Lorenzo; Grassadonia, Antonio; Moscetti, Luca; Portarena, Ilaria; Rossi, Emanuela; Marchetti, Paolo Journal: Critical reviews in oncology/hematology Issue: Volume 98(2016) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lapatinib and Letrozole as First-Line Therapy for Metastatic Breast Cancer: Case Report of Bone Metastasis 18 Years Later. Issue 6 (November 2013) Authors: Mariani, Gabriella; Ricchini, Francesca; Sica, Lorenzo; Bianchi, Giulia Valeria Journal: Tumori Issue: Volume 99:Issue 6(2013) Page Start: e264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metastatic Breast Cancer Treated with Lapatinib with a Prolonged Benefit: A Case Report and a Review of Therapeutic Options Available. Issue 6 (November 2013) Authors: Bianchi, Giulia Valeria; Duca, Matteo; Sica, Lorenzo; Mariani, Gabriella Journal: Tumori Issue: Volume 99:Issue 6(2013) Page Start: e269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge. (June 2016) Authors: Triulzi, Tiziana; Bianchi, Giulia Valeria; Tagliabue, Elda Journal: Future oncology Issue: Volume 12:Number 11(2016) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognosis of women with early breast cancer and PIK3CA mutations. Issue 3 (June 2015) Authors: Di Cosimo, Serena; Bianchi, Giulia Valeria; Bregni, Giacomo; de Braud, Filippo Journal: Breast Issue: Volume 24:Issue 3(2015) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Single Institution trial of anthracycline‐ and taxane‐based chemotherapy for operable breast cancer: The ASTER study. Issue 2 (27th February 2019) Authors: Mariani, Gabriella; Galli, Giulia; Cavalieri, Stefano; Valagussa, Pinuccia; Bianchi, Giulia Valeria; Capri, Giuseppe; Cresta, Sara; Ferrari, Laura; Damian, Silvia; Duca, Matteo; de Braud, Filippo; Moliterni, Angela Journal: Breast journal Issue: Volume 25:Issue 2(2019) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial. Issue 12 (17th December 2021) Authors: Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young‐Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; De Cecco, Loris; Tseng, Ling‐Ming; Liu, Mei‐Ching; Bermejo, Begoña; Semiglazov, Vladimir; Viale, Giulia; de la Haba‐Rodriguez, Juan; Oh, Do‐Yo... Journal: Molecular oncology Issue: Volume 16:Issue 12(2022) Page Start: 2355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗